Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity

This publication has 31 references indexed in Scilit:

• Major Carbohydrate Antigen ofEchinococcus multilocularisInduces an Immunoglobulin G Response Independent of αβ⁺CD4⁺T Cells
  Infection and Immunity, 2001
• Combined praziquantel and albendazole chemoprophylaxis in experimental hydatidosis
  Zeitschrift Fur Parasitenkunde-Parasitology Research, 2001
• Successful Treatment of Metronidazole‐ and Albendazole‐Resistant Giardiasis with Nitazoxanide in a Patient with Acquired Immunodeficiency Syndrome
  Clinical Infectious Diseases, 2001
• Nitazoxanide: pharmacokinetics and metabolism in man
  Int. Journal of Clinical Pharmacology and Therapeutics, 2000
• Alveolar Echinococcosis in Humans: The Current Situation in Central Europe and the Need for Countermeasures
  Parasitology Today, 1999
• Experimental investigations on the B and T cell immune response in primary alveolar echinococcosis
  Parasite Immunology, 1999
• Nitric oxide‐mediated immunosuppression following murine Echinococcus multilocularis infection
  Immunology, 1999
• Development of a chemotherapeutic model for the in vitro screening of drugs against Echinococcus granulosus cysts: the effects of an albendazole-albendazole sulphoxide combination
  International Journal for Parasitology, 1996
• Effect of chemotherapy on the larval mass and the long-term course of alveolar echinococcosis
  Hepatology, 1994
• Effect of albendazole sulphoxide on viability of hydatid protoscoleces in vitro
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1986